Tablets for the treatment of alcoholism became available to residents of the UK Alcoholism is a very unpleasant disease that is widespread not only in our country, but also in many other countries. For example, in the UK, between 2022 and 2023, there were more than 1.2 million cases of people admitted to clinics with conditions directly related to alcohol abuse. The UK will become the second European country to officially approve the distribution of the drug Nalmefene (also called Selincro), which can reduce the human body's dependence on alcoholic beverages. The National Institute for Health and Clinical Excellence (NICE) even published an official recommendation for the use of the new drug for people suffering from alcoholism. In UK medicine, these are considered to be men who take more than 7.5 units of alcohol (1 unit = 10 milliliters of pure ethyl alcohol) per day, and women who take more than 5 units. In fact, drinking more than one and a half liters of beer a day, a Briton can already be considered a full-fledged alcoholic. Nalmefene should be taken once a day, one tablet, to reduce a person's need for alcohol. Over time, the patient's desire to drink will disappear completely. Of course, doctors recommend simultaneously enlisting the support of a professional psychiatrist who will help cope with addiction even more effectively. Tablets for the treatment of alcoholism became available to residents of the UK “Many people have difficulty drinking too much alcohol, even though they feel there is no risk to their health. Many people believe that since they have a job and have excellent social relationships with others, it means that alcoholism does not affect them in any way. This is a big misconception,” says NICE expert Professor Carol Longson. According to the results of clinical studies, patients taking the drug reduced alcohol consumption by an average of 1.8 units per day, and also reduced the duration of binge drinking by an average of 3.2 days per month. Long-term use of the drug methodically improves the overall picture and increases the quality of life of the subjects. The drug Nalmefene was developed by specialists from the Danish pharmaceutical company Lundebeck. Despite the fact that the drug itself was developed back in the early 70s of the last century, it began to become widespread only in our time. In the United States, doctors began using the drug in 1995, but it did not go on sale for quite some time. In Europe, the drug was approved for use only in March 2013. And the first country in which Nalmefene began to be sold was Scotland. This happened last fall. The cost of one standard drug in the UK will be just over £42 for 14 tablets. Would you pay this price to reduce your cravings for alcohol within two weeks? If you've read the article this far please like and subscribe - it really helps the channel. Open the link to find thousands of interesting articles: https://wwwwww.youtube.com/...ityt3yt3.ggpht.com/...-v1